Ionis reports fourth quarter and full year 2021 financial results and recent business achievements

Go back to Ionis reports fourth quarter and full year 2021 financial results and recent business achievements

Ionis Pharmaceuticals (IONS) Tops Q4 EPS by $1.13

February 24, 2022 7:13 AM EST

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q4 EPS of $1.41, $1.13 better than the analyst estimate of $0.28. Revenue for the quarter came in at $440 million versus the consensus estimate of $259.15 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

... More